Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bacillus Calmette-Guérin Danish strain 1331
- Development stage
- Unknown
- Lead developer
- AJ Vaccines
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Administration
- Intravesical
01
Overview
VesiCulture is a freeze-dried powder formulation containing live Mycobacterium bovis bacillus Calmette-Guérin (BCG), specifically the Danish strain 1331. It is administered intravesically (directly into the bladder) for the treatment of primary or recurrent carcinoma in situ (CIS) of the urinary bladder and as adjuvant therapy after transurethral resection to prevent recurrence of high-grade and/or relapsing superficial papillary transitional cell carcinoma. The mechanism of action involves stimulating a local immune response within the bladder mucosa that targets residual cancer cells, reducing recurrence risk. The product is not intended for intravenous, subcutaneous, or intramuscular administration and must be prepared under aseptic conditions immediately prior to use[1][3][5].
- Brand names
- VesiCulture
- Other names
- BCGMycobacterium bovis BCG Danish strain 1331
Beyond the preview
Go deeper on Bacillus Calmette-Guérin Danish strain 1331.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bacillus Calmette-Guérin Danish strain 1331.